Literature DB >> 9521614

Substance P induces secretion of immunomodulatory cytokines by human astrocytoma cells.

C Palma1, S Manzini.   

Abstract

In human astrocytoma cell lines, substance P (SP) stimulated interleukin (IL)-8, IL-6, granulocyte macrophage colony-stimulating factor and leukemia inhibitory factor protein secretion. These SP effects were blocked by a specific NK1 tachykinin receptor antagonist. Further, SP stimulation increased the half-life of IL-6 and IL-8 messenger RNAs, suggesting that the synthesis of these cytokines is also regulated post-transcriptionally. SP-induced cytokine release was inhibited by staurosporine and phorbol 12-myristate 13-acetate desensitization suggesting protein kinase C involvement. The demonstration that SP affects cytokine production in glioma cells might be of relevance for the biology of such tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521614     DOI: 10.1016/s0165-5728(97)00167-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

Review 1.  Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification.

Authors:  Eleanor L Davis; Alan R Davis; Zbigniew Gugala; Elizabeth A Olmsted-Davis
Journal:  Bone       Date:  2017-07-15       Impact factor: 4.398

2.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1beta in rats.

Authors:  S S Wong; N N Sun; J D Hyde; L Ruiz; E Meigs; B R Herrin; C D Fastje; S J Macdonald; M L Witten
Journal:  Lung       Date:  2004       Impact factor: 2.584

4.  Elevated serum substance P during simian varicella virus infection in rhesus macaques: implications for chronic inflammation and adverse cerebrovascular events.

Authors:  Andrew N Bubak; Vicki Traina-Dorge; Christina N Como; Brittany Feia; Catherine M Pearce; Laura Doyle-Meyers; Arpita Das; Jayme Looper; Ravi Mahalingam; Maria A Nagel
Journal:  J Neurovirol       Date:  2020-09-22       Impact factor: 2.643

5.  Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.

Authors:  Xiao-Hong Yao; Yi-Fang Ping; Jian-Hong Chen; Dai-Lun Chen; Cheng-Ping Xu; Jiang Zheng; Ji Ming Wang; Xiu-Wu Bian
Journal:  J Neurooncol       Date:  2007-07-05       Impact factor: 4.130

6.  Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.

Authors:  Jing Yu; Jing Wang; Jean Lud Cadet; Jesus A Angulo
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

7.  Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.

Authors:  Jian-Ping Lai; Saien Lai; Florin Tuluc; Morris F Tansky; Laurie E Kilpatrick; Susan E Leeman; Steven D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-19       Impact factor: 11.205

8.  Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.

Authors:  C Palma; M Bigioni; C Irrissuto; F Nardelli; C A Maggi; S Manzini
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

9.  Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.

Authors:  Fariba Mohammadi; Hossein Javid; Amir Reza Afshari; Baratali Mashkani; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2020-05-20       Impact factor: 2.316

10.  Induction of tachykinin production in airway epithelia in response to viral infection.

Authors:  James P Stewart; Anja Kipar; Helen Cox; Catherine Payne; Sylvia Vasiliou; John P Quinn
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.